You may have noticed that this blog now lists the three posts that have been most frequently accessed during the past 30 days. There is a quite satisfactory month-over month growth in overall visitors to this blog, and so I thought it might also be of interest to summarize some additional access statistics that span the past two years, from May 2009 to today.
The post that generated most all-time interest was the one announcing the launch of the drug repurposing discussion group on LinkedIn — and this one leads by a large margin. Ranks 2 to 4 are taken by the life science patent highlights of December 2010, January 2011, and March 2011, respectively. On rank 5 is the July 2010 post that announced the publication of our Drug Repositioning Report and the cooperation with Coleman Research Group for telephone consulting assignments. Also popular: ” The Winds Of Change” for drug discovery, and the August 2010 post on our practice of employing Open Source Intelligence to satisfy our customers. All these items continue to accrue hits.
Traffic statistics show LinkedIn to be the leading referring site to our blog (not very surprising, since we promote most new posts there), followed by Google which gives us a backgound of hits coming from keyword searches. Referrals from Twitter (we are @hmpharmacon there; please follow) have remained infinitesimal, although our steadily increasing quality followership there receives promotions for every blog post as well. Geographically, the majority of visitors to our blog hails from the United States – as was of course expected; but if you accrete all visitors from European Union countries the EU comes in as a not-too-distant second. Recently we are seeing more and more hits from Asia – India, Russia, Korea, even Ukraine and Iran. Canada and Australia do not seem to have noticed us yet.Most visitors (84%) use some version of MS Windows; Apple’s Macs register only at 8%, but yes, some are coming to us even through there iPhones. Slight surprise: only slightly more then half use Internet Explorer; more than a quarter use Firefox. Other browsers register only on a minimal level.
We will continue to supply you with information on things that resonate… that are, as the saying goes, “hot.” Don’t forget, H.M. Pharma Consultancy believes that the hottest insights can be gained from what has already been reported but sank like a stone because its relevant context is not (yet) accessible to search engines, and therefore not consistently found and exploited. There is a universe of knowledge languishing out there; lets go and make use of it.